Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Glycogen synthase kinase-3 levels and phosphorylation undergo large fluctuations in mouse brain during development.

Beurel E, Mines MA, Song L, Jope RS.

Bipolar Disord. 2012 Dec;14(8):822-30. doi: 10.1111/bdi.12023.

PMID:
23167932
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation.

Eom TY, Jope RS.

Biol Psychiatry. 2009 Sep 1;66(5):494-502. doi: 10.1016/j.biopsych.2009.04.015. Epub 2009 Jun 11.

PMID:
19520363
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

Li X, Rosborough KM, Friedman AB, Zhu W, Roth KA.

Int J Neuropsychopharmacol. 2007 Feb;10(1):7-19. Epub 2006 May 4.

PMID:
16672106
[PubMed - indexed for MEDLINE]
4.

Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice.

Mines MA, Jope RS.

Cell Signal. 2012 Jul;24(7):1398-405. doi: 10.1016/j.cellsig.2012.03.001. Epub 2012 Mar 10.

PMID:
22434044
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Functional significance of glycogen synthase kinase-3 regulation by serotonin.

Polter AM, Yang S, Jope RS, Li X.

Cell Signal. 2012 Jan;24(1):265-71. doi: 10.1016/j.cellsig.2011.09.009. Epub 2011 Sep 17.

PMID:
21946431
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3.

Clodfelder-Miller B, De Sarno P, Zmijewska AA, Song L, Jope RS.

J Biol Chem. 2005 Dec 2;280(48):39723-31. Epub 2005 Sep 22.

PMID:
16179343
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine.

Roh MS, Eom TY, Zmijewska AA, De Sarno P, Roth KA, Jope RS.

Biol Psychiatry. 2005 Feb 1;57(3):278-86.

PMID:
15691529
[PubMed - indexed for MEDLINE]
8.

Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.

Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitomi M, Stacey DW.

BMC Cell Biol. 2006 Aug 30;7:33.

PMID:
16942622
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain.

Li X, Friedman AB, Roh MS, Jope RS.

J Neurochem. 2005 Feb;92(3):701-4.

PMID:
15659239
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
11.

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.

De Sarno P, Li X, Jope RS.

Neuropharmacology. 2002 Dec;43(7):1158-64.

PMID:
12504922
[PubMed - indexed for MEDLINE]
12.

Early undernutrition increases glycogen content and reduces the activated forms of GSK3, AMPK, p38 MAPK, and JNK in the cerebral cortex of suckling rats.

Lizárraga-Mollinedo E, Fernández-Millán E, de Miguel-Santos L, Martínez-Honduvilla CJ, Alvarez C, Escrivá F.

J Neurochem. 2010 Jan;112(1):123-33. doi: 10.1111/j.1471-4159.2009.06434.x. Epub 2009 Oct 15.

PMID:
19840222
[PubMed - indexed for MEDLINE]
13.

Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1).

Kim JW, Lee JE, Kim MJ, Cho EG, Cho SG, Choi EJ.

J Biol Chem. 2003 Apr 18;278(16):13995-4001. Epub 2003 Feb 12.

PMID:
12584189
[PubMed - indexed for MEDLINE]
Free Article
14.

BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents.

Mai L, Jope RS, Li X.

J Neurochem. 2002 Jul;82(1):75-83.

PMID:
12091467
[PubMed - indexed for MEDLINE]
15.

Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.

Polter A, Beurel E, Yang S, Garner R, Song L, Miller CA, Sweatt JD, McMahon L, Bartolucci AA, Li X, Jope RS.

Neuropsychopharmacology. 2010 Jul;35(8):1761-74. doi: 10.1038/npp.2010.43. Epub 2010 Mar 31.

PMID:
20357757
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.

Montori-Grau M, Tarrats N, Osorio-Conles O, Orozco A, Serrano-Marco L, Vázquez-Carrera M, Gómez-Foix AM.

Cell Signal. 2013 May;25(5):1318-27. doi: 10.1016/j.cellsig.2013.02.014. Epub 2013 Feb 20.

PMID:
23453973
[PubMed - indexed for MEDLINE]
17.

In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors.

De Sarno P, Bijur GN, Zmijewska AA, Li X, Jope RS.

Neurobiol Aging. 2006 Mar;27(3):413-22. Epub 2005 Apr 26.

PMID:
16464655
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.

Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS.

Neuropsychopharmacology. 2004 Aug;29(8):1426-31.

PMID:
15039769
[PubMed - indexed for MEDLINE]
Free PMC Article
19.
20.

Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38.

Nemoto T, Miyazaki S, Kanai T, Maruta T, Satoh S, Yoshikawa N, Yanagita T, Wada A.

Eur J Pharmacol. 2010 Aug 25;640(1-3):20-8. doi: 10.1016/j.ejphar.2010.04.048. Epub 2010 May 12.

PMID:
20470771
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk